Doctor, professor-level senior engineer, provincial and municipal level "talent plan" special expert, provincial and municipal level high-level talent innovation team leader.
He was a Postdoctoral Fellow at University of Basel, Switzerland (supervisor: Prof. Bernd Giese, Member of the two Chambers of the American and German Academy of Sciences，Nobel Prize nominated) Senior Research Fellow, Institute of Organic Chemistry, University of Basel; Bachelor's degree in a chemist base of Sun Yat-sen University; He received his master and Doctor degree in the State Key Laboratory of Organic Life Sciences, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences;
Focusing on targeted peptide innovation drug screening and preclinical development, complicated peptide API and preparations industrialization development and registration, led and participated in more than 30 new peptide drug development projects and obtained 4 clinical approvals. Applied for and produced 12 projects, 1 national Torch Plan, 5 provincial and municipal science and technology key projects, 20 authorized invention patents, 1district, won the first prize for provincial and municipal science and technology progress, provincial academic leader reserve;
He has worked in many R&D leading domestic pharmaceutical enterprises. As a co-founder, founded a biotechnology company with more than 180 people, which was incorporated into the IPO of listed enterprises;
Special expert of the National 1,000 Talents Plan, doctoral supervisor at the Department of Engineering Physics, Tsinghua University.
Department of Nuclear Physics, Engineering Physics, nuclear Physics Science and Technology, Tsinghua University, postdoctoral fellow at Stanford University (tutor Rebecca Fahrig). An editorial board of the journal CT Theory and Applied Research, director of the Chinese Physical Vision Society, member of the First Committee of Intelligent Imaging Branch of Chinese Society of Physical Vision, evaluation expert of the National Natural Science Foundation of China Project and the Talent Project of the Ministry of Education, member of American Association of Medical Physicists (AAPM);
He has worked in GE Global R & D Center and GE Medical Group (Senior Scientist) and RefleXion Medical Corporation (Chief Scientist); participated in 256 rows of high-end medical diagnostic CT machines (Revolution CT) and large volume CT spectrum imaging (Revolution CT GSI Xtream) project, as the chief scientist developing the world's first PET and CT-based biology-guided radiation therapy instrument; focusing on radiation imaging, especially computed tomography imaging (the frontier scientific research and technological innovation of CT) and its application in medical diagnosis and image guidance; so far, he has published more than 80 academic papers. 15 American patents and 26 Chinese patents.
Professor, University of Basel, Switzerland
Member of the American Academy of Arts and Sciences, Member of the German Academy of Sciences, Healthytide's scientific consultant.
He has received the Tetrahedron Prize, Emile. Fischer Prize in Chemistry of Germany, Norris Prize in Physical organic chemistry of the American Chemical Society, Paracelsus Prize of the Chemical society. Giese free radical reaction named after him, as well as Giese index of electron transfer Markus equation. Nobel Prize nominee;
He has served as founder and board chairman and scientific advisor of several new cutting-edge Swiss biotechnology companies. He has been the world's leading researcher in the field of electronic transfer mechanism of peptides, proteins, and DNA in vivo for 33 clinical phases II studies, and his papers are among the top 50 most cited in the world.
Ph. D., Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (Academician Tang Yong, mentor); Ph. D. Director of The Scripps Research Institute and Department of Molecular Biology, University of California, Santa Barbara. He is currently a professor and a director of the Department of Institute of Organic Chemistry, Xiamen University, Healthytide's scientific consultant.
His research field mainly includes the innovative method construction and industrial application of complex chiral drug molecules and their key chiral blocks;
He has won the National Natural Science Foundation of China for Outstanding Young Scholars (2016), Ministry of Education of China for Young Yangtze Scholars (2017), the National Natural Science Foundation of China for Distinguished Young Scholars (2021), Yao Mingkant Life Chemistry Research Award (2021), Nan Qiang Distinguished Professor (2022), a fellow of the Royal Chemical Society of Great Britain（FRSC，2022), etc.
Deputy Director of Department of Organic Chemistry, ETH Zurich, Healthytide's scientific consultant.
She studied chemistry at Goethe University in Frankfurt (with advisor Gerhard Quinkert) in 1993, and then received her Ph.D. in 1996 from Columbia University in New York (with advisor W. Clark Still); from 1996 to 1998, she was a postdoctoral fellow in Naoya Yamamoto's group at Nagoya University. After that, she received a teaching position at the University of Basel, Switzerland (co-supervisor: Professor Bernd Giese, chief scientific consultant of Healthytide. Assistant Professor of Bachem at the University of Basel, 1999; in 2003, she was promoted to associate professor; professor of Organic Chemistry at ETH in 2011. And now, she is currently a Deputy Director of ETH Organic Chemistry department.
Research areas include cell-penetrating peptides, novel anti-tumor peptides, peptide radionuclide diagnosis, and treatment, etc.
Her research has been recognized with numerous awards, among them the Leonidas Zervas Award of the European Peptide Society (2010), the Pedler Award of the Royal Society of Chemistry (2016), the Inhoffen Medal of the Helmholtz Centre for Infection Research (2017), the Netherlands Scholar Award for Supramolecular Chemistry (2019), the Spark Award of ETH Zurich (2020) and the Arthur C. Cope Scholar Award of the American Chemical Society (2021).
Professor of the University of Fribourg, Switzerland; former President of the Swiss Crystallographic Society, a former member of the Chemistry Department of the Swiss Academy of Sciences, and former Dean of the School of Chemistry, University of Fribourg, Switzerland.
After receiving her doctorate from the University of Karlsruhe in 1994, she worked as a junior lecturer teacher at the University of Geneva; she was appointed Assistant Professor after participating in the Emmy Noether II project of the German Science Foundation and the Swiss National Science Foundation. She taught at Karlsruhe and then at the University of Basel. Since 2006, she has been a full professor at the Department of Chemistry of the University of Fribourg;
Her research areas include antimicrobial peptides, peptide drug metal nanomaterial delivery systems, etc.
In 2011, she was selected for the Research Board of The Swiss Natural Science Foundation (Research concilor, FNS 2011). In 2013, she was elected a Fellow of Thof the American Chemical Society. In 2015, he was elected President of Division IV and Vice-President of the Council of the Swiss Natural Science Foundation. In 2018, she was elected a Fellow of the European Academy of Sciences 2018. He was elected Fellow of Chemistry Europe.
With the mission of "creating better medicine", Hetai Jianyu is committed to building an internationally competitive peptide innovation molecule discovery and application platform.
Read More
Read More
Read More
Read More
Read More
Read More
